Linda Chow, RN Registered Nurse - Psych/Mental Health, Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 17974 Sunrise Dr, Rowland Heights, CA 91748 Phone: 626-203-9609 |
Jihee Kim, FNP Registered Nurse - Medical-Surgical Medicare: Not Enrolled in Medicare Practice Location: 18773 Colima Rd, Rowland Heights, CA 91748 Phone: 626-986-4899 |
Krystel Ann Rodela, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 18494 Buttonwood Ln, Rowland Heights, CA 91748 Phone: 562-639-4282 |
Linh Tran, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 19355 Heritage Pl, Rowland Heights, CA 91748 Phone: 714-390-3793 |
Christine W Karuchi, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 19346 Andrada Dr, Rowland Heights, CA 91748 Phone: 857-204-5918 |
Eric Hong, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1441 Paso Real Ave Spc 2, Rowland Heights, CA 91748 Phone: 562-237-1884 |
News Archive
According to a new report released by the Center for Disease Control, Florida ranks second in the United States for its high percentage of uninsured residents. More than 19 percent, or 3.5 million people, lacked insurance last year.
The racial gap in preventive health care - such as Pap tests, mammograms, and prostate and colorectal cancer screenings - persists and might be larger than previously thought, a study published online in BMC Heath Services Research finds, the Washington Post reports.
Firms vying to tap the fund a $1 billion fund meant to catalyze research on new biologic treatments for cancer and other diseases may be disappointed in the outcome, The Washington Post reports. "[W]ith so many companies applying for a share of the money, many firms got much smaller allotments than requested and said the financial boost won't go as far as they had initially hoped.
Since 1992 the number of deaths linked to breast cancer in Spain has decreased among young and middle aged patients but not among the elderly. Spanish researchers also predict that it will continue to decline over the next decade, although more slowly as observed up until now.
NicOx S.A. announced the presentation of detailed 26-week efficacy, safety and tolerability data from the second pivotal phase 3 study for naproxcinod (the 302 study) yesterday, at the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
› Verified 8 days ago